Drugs and Devices

FDA approves new drug for heart failure

On July 7, the U.S. Food and Drug Administration (FDA) approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares